NCT05087199

Brief Summary

This study aims to assess the clinical presentation, radiological patterns and outcome of COVID-19 infection in patients with chronic pulmonary disease. Inter-relationship between the severity of COVID-19 infection and chronic pulmonary diseases.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

November 2, 2021

Status Verified

October 1, 2021

Enrollment Period

8 months

First QC Date

October 20, 2021

Last Update Submit

October 26, 2021

Conditions

COVID-19Chronic Pulmonary Disease

Keywords

COVID-19Chronic pulmonary disease

Outcome Measures

Primary Outcomes (1)

  • Effect of COVID-19 on patients with chronic pulmonary diseases

    2 weeks after patient confirmation of infection by COVID-19

Interventions

Rt-PCR.DIAGNOSTIC_TEST

Nasopharyngeal swab for Rt-PCR for COVID-19

Also known as: Ct chest, D-dimer, CRP

Eligibility Criteria

Age16 Years - 100 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Community sample with chronic pulmonary diseases

You may qualify if:

  • Subjects with confirmed diagnosis of COVID-19 infection by:
  • RT-PCR And Chest Computed tomography and laboratoty investigations. Patients with chronic chest disease including (COPD, bronchial asthma, ILD, bronchiectasis).

You may not qualify if:

  • Those who are diagnosed with viral pneumonia caused by viruses other than COVID-19.
  • Those who are not confirmed to be COVID-19 with PCR or by radiological and laboratory investigations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19

Interventions

COVID-19 Nucleic Acid Testing

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

COVID-19 TestingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 20, 2021

First Posted

October 21, 2021

Study Start

November 1, 2021

Primary Completion

June 30, 2022

Study Completion

July 30, 2022

Last Updated

November 2, 2021

Record last verified: 2021-10